Delivery Order SPE2DB20D1100-SPE2DB24FB7U9

Award Date 5/14/24
Potential Completion Date 5/15/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,447.54 firm fixed-price contract is for the supply of testosterone cypionate 200 mg/mL, with a period of performance through March 29, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,599.84 firm fixed-price contract is for the delivery of testosterone cypionate 200 mg/mL medication, with a completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $1,052.14 to supply Testosterone Cypionate 200 mg/ml. The contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,018.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical sourcing and distribution company. The contract is for the delivery of testosterone cypionate 200 mg/mL medication to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of testosterone cypionate 200 mg/mL, a specialty medication. The delivery order has a ceiling value of $1,399.09 and a performance period ending on July 25, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical for $2,310.37. The order is for testosterone cypionate 200 mg/mL, a prescription medication. This award is not set aside for any specific business category. The contract has an ultimate completion date of August 20, 2024 and is a Firm Fixed Price agreement. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,261.51 firm fixed-price delivery order is for the supply of testosterone cypionate 200 mg/mL medication. The contract has an ultimate completion date of February 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of testosterone cypionate 200 mg/mL. The award, valued at $1,911.32, has a firm fixed price and a completion date of September 24, 2024. The contract is not associated with a set-aside program. AmerisourceBergen, through its extensive supply chain network, provides a wide range of pharmaceutical products and medical supplies to support...
This federal contract award to AmerisourceBergen Drug Corp is for the delivery of 200 mg/mL testosterone cypionate. The $1,416.00 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on March 10, 2025, with a completion date of March 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,787.64, is for the supply of testosterone cypionate 200 mg/mL injections. It is a firm fixed-price contract with a completion date of March 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB7U9
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of testosterone cypionate 200 mg/mL medication. The contract has a firm fixed price of $1,378.62 and a completion date of May 15, 2024. It is not associated with any set-aside program.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 8/13/24, 12:01 PM